Medicinal Cannabis Matters – A weekly round-up
Medicinal Cannabis Matters – Our weekly round up of what is happening in the medical cannabis world, and how the industry is evolving to provide better access to patients who need it.
Welcome to our first-ever Medicinal Cannabis Matters blog post, our new weekly round-up of what has been happening in the world of medicinal cannabis. Read this week’s top news stories, from our CEO Gary Whipp
This week, hot off the press: Germany legalises the recreational use of cannabis. We consider how medicinal cannabis might be the gateway out of drug addiction. We also take a look at how the cannabis entourage effect is 100% a real thing. Meanwhile, over in Europe, Spain is reviewing Medicinal cannabis proposals and finally, Bedrocan has announced the opening of its first cannabis research unit.
Germany has hit the headlines today as they announce the legalisation of recreational cannabis. Smoking cannabis in many public spaces will become legal from 1 April, with or without a medical condition. Read more on the BBC website.
How Cannabis might be the gateway out of Drug Addiction
New research has found that those using illicit drugs turned to medicinal cannabis to manage their cravings meaning medicinal cannabis might be a beneficial tool for some people who want to better control their unregulated stimulant use. Read more
How the cannabis entourage effect is 100% a real thing
A new medical study shows how terpenes and cannabinoids react and just how Terpenes, Cannabinoids, and Flavonoids all play a big role regulating cannabis in the human body!
Read more
Spain reviewing Medicinal cannabis proposals
Spain’s newly appointed health minister has said that the country’s long-awaited medical cannabis law will be ready ‘in the coming months,’ as she makes good on her promise to kickstart progress. Read more
Bedrocan opening its first cannabis research unit
Bedrocan has opened its own clinical research unit to conduct research into the effects of the cannabis products. CEO Jaap Erkelens says “Bedrocan can now conduct targeted research into the effects of the cannabis products”
Read more
Disclaimer:
This blog post and the following featured articles is for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
